EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry
Epidermal Growth Factor Receptor (EGFR) overexpression or its mutation mediates the sustaining proliferative signaling, which is an important hallmark of cancer. Human EGFR-targeting monoclonal antibody (mAb) therapy such as cetuximab has been approved for clinical use in patients with colorectal ca...
Main Authors: | Nohara Goto, Hiroyuki Suzuki, Tomohiro Tanaka, Kenichiro Ishikawa, Tsunenori Ouchida, Mika K. Kaneko, Yukinari Kato |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/12/3/42 |
Similar Items
-
Development of Highly Sensitive Anti-Mouse HER2 Monoclonal Antibodies for Flow Cytometry
by: Tsunenori Ouchida, et al.
Published: (2023-08-01) -
Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134
by: Mika K. Kaneko, et al.
Published: (2018-07-01) -
A Novel Anti-CD44 Variant 3 Monoclonal Antibody C<sub>44</sub>Mab-6 Was Established for Multiple Applications
by: Hiroyuki Suzuki, et al.
Published: (2023-05-01) -
Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C<sub>44</sub>Mab-94 against Gastric Carcinomas
by: Hiroyuki Suzuki, et al.
Published: (2023-07-01) -
Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry
by: Nami Tateyama, et al.
Published: (2022-12-01)